 Participant will be assigned to a dose level of temsirolimus based on when participant joined this study. Up to 2 dose levels of temsirolimus will be tested. Up to 6 participants will be enrolled at each dose level. The first group of participants will receive the lowest dose level. The second group will receive a higher dose than the group before it, if no intolerable side effects were seen. 